Astrazeneca Pharma India standalone net profit rises 95.25% in the December 2024 quarter
Sales rise 43.98% to Rs 440.29 crore
Net profit of Astrazeneca Pharma India rose 95.25% to Rs 30.85 crore in the quarter ended December 2024 as against Rs 15.80 crore during the previous quarter ended December 2023. Sales rose 43.98% to Rs 440.29 crore in the quarter ended December 2024 as against Rs 305.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales440.29305.79 44 OPM %17.494.92 -PBDT84.6424.10 251 PBT75.5720.40 270 NP30.8515.80 95Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2025 | 7:38 AM IST